Bryce Joanne's most recent trade in Disc Medicine Inc was a trade of 27,250 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 27,250 | 27,250 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2024 | 18,165 | 23,665 | - | 0 | Common Stock | |
Disc Medicine Inc
|
Bryce Joanne | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 27 Dec 2023 | 3,000 | 5,500 | - | 9.9 | 29,580 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 3,000 | 73,745 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.22 per share. | 12 Dec 2023 | 2,500 | 2,500 | - | 65.2 | 163,062 | Common Stock |
Disc Medicine Inc
|
Bryce Joanne | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 2,500 | 2,253 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc
|
Bryce Joanne | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 12 Dec 2023 | 2,500 | 5,000 | - | 2.7 | 6,625 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.55 per share. | 05 Dec 2023 | 1,293 | 2,600 | - | 56.5 | 73,115 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.29 per share. | 05 Dec 2023 | 1,148 | 3,893 | - | 55.3 | 63,478 | Common Stock |
Disc Medicine Inc
|
Bryce Joanne | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 755 | 752 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 05 Dec 2023 | 755 | 5,041 | - | 1.0 | 763 | Common Stock |
Disc Medicine Inc
|
Bryce Joanne | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 526 | 0 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc
|
Bryce Joanne | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 05 Dec 2023 | 526 | 4,286 | - | 1.0 | 531 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 57.06 per share. | 05 Dec 2023 | 100 | 2,500 | - | 57.1 | 5,706 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 4,521 | 1,507 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 01 Aug 2023 | 4,521 | 5,781 | - | 1.0 | 4,566 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.63 per share. | 01 Aug 2023 | 3,067 | 2,714 | - | 49.6 | 152,213 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.50 per share. | 01 Aug 2023 | 1,454 | 1,260 | - | 50.5 | 73,420 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2023 | 7,880 | 526 | - | - | Stock Option (Right to Buy) | |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share. | 28 Jun 2023 | 7,880 | 11,332 | - | 1.0 | 7,959 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 50.50 per share. | 28 Jun 2023 | 4,905 | 1,619 | - | 50.5 | 247,681 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.30 per share. | 28 Jun 2023 | 4,808 | 6,524 | - | 49.3 | 237,042 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 51.23 per share. | 28 Jun 2023 | 359 | 1,260 | - | 51.2 | 18,391 | Common Stock |
Disc Medicine Inc
|
Joanne Bryce | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2022 | 33,847 | 33,847 | - | - | Stock Option (Right to Buy) |